biopsy metastasis
Item
metastatic breast cancer confirmed by biopsy
boolean
C0005558 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
therapy
Item
prior adjuvant/neoadjuvant treatment allowed
boolean
C0087111 (UMLS CUI [1])
measurable disease
Item
measurable disease
boolean
C1513041 (UMLS CUI [1])
performance status
Item
able to perform activities of daily living with minimal assistance
boolean
C1518965 (UMLS CUI [1])
age
Item
age 18 years or older
boolean
C0001779 (UMLS CUI [1])
bone marrow, liver and kidney function
Item
adequate bone marrow, liver and kidney function
boolean
C0232741 (UMLS CUI [1])
C0005953 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
heart
Item
normal heart function
boolean
C0018787 (UMLS CUI [1])
informed consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
peripheral neuropathy
Item
pre-existing moderate peripheral neuropathy
boolean
C0031117 (UMLS CUI [1])
heart disease
Item
history of significant heart disease
boolean
C0018799 (UMLS CUI [1])
meningeal metastases
Item
meningeal metastases.
boolean
C0027627 (UMLS CUI [1,1])
C0025284 (UMLS CUI [1,2])
chemotherapy
Item
prior chemotherapy for metastatic breast cancer
boolean
C0392920 (UMLS CUI [1])
measurable disease
Item
no measurable disease (including bone only, pleural effusions, etc.)
boolean
C1513041 (UMLS CUI [1])
herceptin
Item
receiving herceptin therapy.
boolean
C0338204 (UMLS CUI [1])
pregnancy, lactation
Item
women who are pregnant or lactating.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
additional inclusion/exclusion criteria
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
boolean